Physical Activity and Cognition Study
- Conditions
- Aging
- Registration Number
- NCT02773121
- Lead Sponsor
- Boston University
- Brief Summary
The goal of this research study is to examine whether an intervention to increase physical activity using a body-worn sensor affects cognitive (thinking) processes.
- Detailed Description
The overall duration of participation in this research study is approximately 4 months. During this time, three study visits will be required. The first visit is for informed consent and screening, the second visit is for baseline fitness and cognitive testing, and the third visit is for follow-up fitness and cognitive testing after a 12-week physical activity monitoring program. Participants will be randomized to one of two study arms, a physical activity monitoring arm and a flexibility and balance arm. Both study arms involve wearing a physical activity sensor and monitoring physical activity for a duration of 12 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
- Non-smoking
- Age between 55-85 years
- Sedentary status (physically inactive; not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months)
- Generally healthy men and women
- Living in the greater Boston area
- Available for the 4 month duration of the study
- Native-English speaking or fluent in English (must have attended elementary school and higher in English)
-
Poor vision that cannot be corrected with glasses or contact lenses
-
Presence of an acute infection
-
Diagnosis of kidney failure
-
Diagnosis of liver disease
-
Diagnosis of thyrotoxicosis/hyperthyroidism
-
Diagnosis of cancer
-
Past or present conditions that affect cognitive functioning:
- learning disability
- neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
- psychiatric disorders or conditions (depression, anxiety disorder, etc.)
-
Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and moderate-intensity physical activity:
- heart conditions (e.g. heart attack, arrhythmias, etc.)
- circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.)
- respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
- current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
- diagnosis of electrolyte disorder or abnormality
- presence of diabetes mellitus
-
Obesity
-
Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.)
-
Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.)
-
Implanted medical devices, such as a pacemaker or defibrillator
-
Unavailable for the approx. 4-month duration of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Cognition 80-90 minutes Change in cognitive task performance post-intervention compared to baseline
Aerobic Fitness 30 minutes Change aerobic fitness measured with treadmill test post-intervention
- Secondary Outcome Measures
Name Time Method Functional fitness: Five Times Sit to Stand 10 min Change in performance in the Five Times Sit to Stand test post-intervention
Functional fitness: Timed Get Up and Go 10 min Change in performance in the Timed Get Up and Go test post-intervention compared to baseline
Functional fitness: Flexibility 10 min Change in performance in the Sit and Reach test post-intervention
Physical activity 12 weeks Greater overall moderate-intensity physical activity time and step count and lower sedentary time in the physical activity monitoring than the flexibility and balance group
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Boston University School of Medicine
🇺🇸Boston, Massachusetts, United States
Boston University School of Medicine🇺🇸Boston, Massachusetts, United States